Schroder Investment Management Group Arrowhead Pharmaceuticals, Inc. Transaction History

Schroder Investment Management Group

  • $94.5 Billion
  • Q3 2024

A detailed history of Schroder Investment Management Group transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 208,560 shares of ARWR stock, worth $4.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
208,560
Previous 55,349 276.81%
Holding current value
$4.09 Million
Previous $1.44 Million 180.74%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$19.36 - $29.54 $2.97 Million - $4.53 Million
153,211 Added 276.81%
208,560 $4.04 Million
Q2 2024

Aug 12, 2024
SELL
$21.87 - $28.24 $11,875 - $15,334
-543 Reduced 0.97%
55,349 $1.44 Million
Q1 2024

May 14, 2024
SELL
$27.21 - $39.48 $2.49 Million - $3.61 Million
-91,506 Reduced 62.08%
55,892 $1.6 Million
Q4 2023

Feb 13, 2024
SELL
$21.2 - $31.03 $783,721 - $1.15 Million
-36,968 Reduced 20.05%
147,398 $4.51 Million
Q3 2023

Nov 14, 2023
BUY
$26.2 - $36.08 $62,984 - $86,736
2,404 Added 1.32%
184,366 $4.95 Million
Q4 2022

Feb 10, 2023
BUY
$28.0 - $40.56 $178,360 - $258,367
6,370 Added 3.63%
181,962 $7.38 Million
Q3 2022

Nov 10, 2022
BUY
$29.63 - $48.31 $2.03 Million - $3.31 Million
68,477 Added 63.93%
175,592 $5.8 Million
Q2 2022

Aug 11, 2022
SELL
$27.79 - $50.61 $2.11 Million - $3.84 Million
-75,789 Reduced 41.44%
107,115 $3.77 Million
Q1 2022

May 16, 2022
BUY
$39.62 - $69.97 $3.6 Million - $6.35 Million
90,819 Added 98.63%
182,904 $8.34 Million
Q4 2021

Feb 14, 2022
BUY
$58.09 - $82.51 $1.34 Million - $1.9 Million
23,049 Added 33.39%
92,085 $6.11 Million
Q3 2021

Nov 12, 2021
BUY
$58.38 - $84.96 $1.03 Million - $1.5 Million
17,644 Added 34.33%
69,036 $4.31 Million
Q2 2021

Aug 13, 2021
SELL
$62.15 - $90.32 $323,615 - $470,296
-5,207 Reduced 9.2%
51,392 $4.26 Million
Q1 2021

May 17, 2021
SELL
$61.35 - $90.47 $706,690 - $1.04 Million
-11,519 Reduced 16.91%
56,599 $3.75 Million
Q4 2020

Feb 16, 2021
BUY
$43.82 - $85.37 $27,781 - $54,124
634 Added 0.94%
68,118 $5.23 Million
Q3 2020

Nov 13, 2020
SELL
$33.21 - $51.27 $66,851 - $103,206
-2,013 Reduced 2.9%
67,484 $2.96 Million
Q1 2020

May 15, 2020
BUY
$20.56 - $63.12 $1.43 Million - $4.39 Million
69,497 New
69,497 $2.01 Million

Others Institutions Holding ARWR

# of Institutions
294
Shares Held
90.8M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email